The Department of Justice and the Federal Trade Commission have announced a civil enforcement action against Xlear Inc. and its CEO Nathan Jones for alleged violations of the COVID-19 Consumer Protection Act and the FTC Act.

The complaint was filed in Utah, according to a DOJ statement, and alleges that Xlear advertised that its saline nasal spray could prevent or treat COVID-19, without any credible scientific data to back it up. The government also claimed the defendants made deceptive statements about several scientific studies to bolster their claims that the spray could prevent COVID-19.